On May 6-7, Tom traveled to Long Beach, CA to participate in the 2019 PDA Cell & Gene Therapy Conference hosted by the Pharmaceuticals Drug Association (PDA).
 
The discussion Tom participated in, moderated by Michael Blackton of Adaptimmune, was focused on the patient’s perspective of CAR-T cell therapy and how the treatment affects the patient’s experience both while being treated and following. 
 
Many thanks to Michael, and to Brooke Schneider and the entire PDA committee for the invitation to participate, as well as thanks to ValSource for sponsoring the session Tom participated in!